Yi Hao

Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Efficacy and Safety of Neoadjuvant Chemotherapy Followed by CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With HR-Positive, HER2-Negative Breast Cancer: A Retrospective Single-Centre Cohort Analysis.

Efficacy and Safety of Neoadjuvant Chemotherapy Followed by CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With HR-Positive, HER2-Negative Breast Cancer: A Retrospective Single-Centre Cohort Analysis.

Journal: Cancer medicine
Published: June 06, 2026

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 17, 2025

Decoding the GRAS code: evolutionary phylogeny and functional diversification of a key gene family in Populus simonii.

Decoding the GRAS code: evolutionary phylogeny and functional diversification of a key gene family in Populus simonii.

Journal: BMC plant biology
Published: March 29, 2025

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 29, 2024

Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption.

Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 01, 2024

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 22, 2024

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

Journal: Cancer medicine
Published: March 14, 2024

Programmable Peptides Activated Macropinocytosis for Direct Cytosolic Delivery.

Programmable Peptides Activated Macropinocytosis for Direct Cytosolic Delivery.

Journal: Advanced healthcare materials
Published: April 12, 2023

Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory.

Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory.

Journal: Critical reviews in oncology/hematology
Published: August 27, 2022

A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer.

A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer.

Journal: Journal of immunology research
Published: March 27, 2022

Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape.

Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape.

Journal: Molecular cancer
Published: March 01, 2022

Riddle of the Sphinx: Emerging Role of Transfer RNAs in Human Cancer.

Riddle of the Sphinx: Emerging Role of Transfer RNAs in Human Cancer.

Journal: Frontiers in pharmacology
Published: October 14, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026